drugset / Trial / NCT06437054
Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is a prospective, randomized pilot study. To verify an efficacy/safety of the mixed drug injectable delivery vehicle for treating intractable hearing loss. Hearing test, endoscopy of tympanic membrane and CT scans will be conducted after intratympanic treatment for evaluation.
Timeline
- Start
- 2026-12-15
- Primary completion
- 2026-12-15
- Completion
- 2028-09-30
Outcome
Outcome not reported
Stopped (Enrollment): “This study was withdrawn before enrollment due to challenges in participant recruitment. A revised study protocol will be initiated under a new research project.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hyaluronic Acid | Other / unclassified | 20 mg | Intrathecal |
| Background | Dexamethasone | Small molecule | 5 mg/ml | Intrathecal |